Paper31360331
Structural Biology and Protein Engineering of Thrombolytics.
Mican J and 3 others. Comput Struct Biotechnol J, 2019. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Structural Biology and Protein Engineering of Thrombolytics. Papers, record 31360331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31360331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References357
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9843178 | Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator. | Thromb Haemost | 1998 | https://conductscience.org/library/papers/9843178 | PubMed |
| 2 | 30342946 | Lipid modification of staphylokinase and its implications on stability and activity. | Int J Biol Macromol | 2019 | https://conductscience.org/library/papers/30342946 | PubMed |
| 3 | 2110366 | Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2110366 | PubMed |
| 4 | 26555266 | The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26555266 | PubMed |
| 5 | 1731899 | A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators. | Biochemistry | 1992 | https://conductscience.org/library/papers/1731899 | PubMed |
| 6 | 1315765 | Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1315765 | PubMed |
| 7 | 12727218 | Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator. | Biochem Biophys Res Commun | 2003 | https://conductscience.org/library/papers/12727218 | PubMed |
| 8 | 5967844 | Plasminogen activator in saliva of the vampire bat Desmodus rotundus. | Nature | 1966 | https://conductscience.org/library/papers/5967844 | PubMed |
| 9 | 7629153 | Variants of tissue-type plasminogen activator which display substantially enhanced stimulation by fibrin. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7629153 | PubMed |
| 10 | 22775207 | Serine-proteases as plasminogen activators in terms of fibrinolysis. | J Pharm Pharmacol | 2012 | https://conductscience.org/library/papers/22775207 | PubMed |
| 11 | 9446629 | Plasminogen activation by streptokinase via a unique mechanism. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9446629 | PubMed |
| 12 | 1900431 | Tissue plasminogen activator has an O-linked fucose attached to threonine-61 in the epidermal growth factor domain. | Biochemistry | 1991 | https://conductscience.org/library/papers/1900431 | PubMed |
| 13 | 3930494 | Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. | J Biol Chem | 1985 | https://conductscience.org/library/papers/3930494 | PubMed |
| 14 | 2989113 | Nucleotide sequence of the streptokinase gene from Streptococcus equisimilis H46A. | Gene | 1985 | https://conductscience.org/library/papers/2989113 | PubMed |
| 15 | 22018738 | Expression and large-scale production of the biochemically active human tissue-plasminogen activator in hairy roots of Oriental melon (Cucumis melo). | J Biosci Bioeng | 2012 | https://conductscience.org/library/papers/22018738 | PubMed |
| 16 | 26074048 | Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy. | J Thromb Haemost | 2015 | https://conductscience.org/library/papers/26074048 | PubMed |
| 17 | 10961989 | Leucine 42 in the fibronectin motif of streptokinase plays a critical role in fibrin-independent plasminogen activation. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10961989 | PubMed |
| 18 | 8259556 | Molecular conversions of recombinant staphylokinase during plasminogen activation in purified systems and in human plasma. | Thromb Haemost | 1993 | https://conductscience.org/library/papers/8259556 | PubMed |
| 19 | 23970549 | Full time course kinetics of the streptokinase-plasminogen activation pathway. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23970549 | PubMed |
| 20 | 8601101 | Antibodies to streptokinase. | BMJ | 1996 | https://conductscience.org/library/papers/8601101 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909374 | Biomimetic sequential targeted nanoplatform for synergistic thrombolysis in ischemic stroke. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42909374 | PubMed |
| 42894449 | Tenecteplase for Acute Ischemic Stroke: From Molecular Bioengineering to Phase III Pivotal Trials. | J Stroke | 2026 | https://conductscience.org/library/papers/42894449 | PubMed |
| 42490834 | Rather a versatile multi-tool than a sword: an integral role of the plasminogen system in health and disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42490834 | PubMed |
| 41873769 | Rapid screening of staphylokinase protein variants using an unpurified cell-free expression system. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/41873769 | PubMed |
| 41684937 | Mapping the Mutational Landscape for Streptokinase Binding to Plasminogen. | bioRxiv | 2026 | https://conductscience.org/library/papers/41684937 | PubMed |
| 41045044 | Thrombolytic proteins profiling: High-throughput activity, selectivity, and resistance assays. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/41045044 | PubMed |
| 41023073 | Epitope mapping strategies for immunogenicity mitigation in streptokinase therapeutics: an in-silico study. | Sci Rep | 2025 | https://conductscience.org/library/papers/41023073 | PubMed |
| 40331091 | Thrombolysis for acute ischaemic stroke: development and update. | Brain Commun | 2025 | https://conductscience.org/library/papers/40331091 | PubMed |
| 39838000 | Streptokinase is dispensable in Streptococcus dysgalactiae subspecies equisimilis infections of human dendritic cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/39838000 | PubMed |
| 39271530 | Acute ischemic stroke: research perspective vs. clinical practice. | Neurosurg Rev | 2024 | https://conductscience.org/library/papers/39271530 | PubMed |
| 39098853 | Glycosylation: mechanisms, biological functions and clinical implications. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39098853 | PubMed |
| 38686829 | Targeted drug delivery to the thrombus by fusing streptokinase with a fibrin-binding peptide (CREKA): an in silico study. | Ther Deliv | 2024 | https://conductscience.org/library/papers/38686829 | PubMed |
| 38535098 | Sonothrombolysis for Ischemic Stroke. | J Cardiovasc Dev Dis | 2024 | https://conductscience.org/library/papers/38535098 | PubMed |
| 38297113 | Internal fibrinolysis of fibrin clots is driven by pore expansion. | Sci Rep | 2024 | https://conductscience.org/library/papers/38297113 | PubMed |
| 38286483 | Anti-stroke biologics: from recombinant proteins to stem cells and organoids. | Stroke Vasc Neurol | 2024 | https://conductscience.org/library/papers/38286483 | PubMed |
| 37966570 | Therapeutic management of ischemic stroke. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/37966570 | PubMed |
| 37781366 | Immunogenic epitope scanning in bacteriolytic enzymes Pal and Cpl-1 and engineering Pal to escape antibody responses. | Front Immunol | 2023 | https://conductscience.org/library/papers/37781366 | PubMed |
| 37765291 | The Recent Applications of PLGA-Based Nanostructures for Ischemic Stroke. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765291 | PubMed |
| 37614611 | The effect of mutation on neurotoxicity reduction of new chimeric reteplase, a computational study. | Res Pharm Sci | 2023 | https://conductscience.org/library/papers/37614611 | PubMed |
| 36942151 | Fibrinolysis: an illustrated review. | Res Pract Thromb Haemost | 2023 | https://conductscience.org/library/papers/36942151 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31360331
GET https://conductscience.org/api/papers/v1/31360331/references?page=2